Skip to main content
. 2023 Mar 3;13:1097911. doi: 10.3389/fonc.2023.1097911

Figure 4.

Figure 4

Kaplan–Meier survival curves of OS of different therapeutic sequences of fruquintinib and regorafenib. mOS, median overall survival.